非心血管并存疾病妇女使用激素避孕的综述全面审查。

IF 1 Q2 Medicine
Minerva ginecologica Pub Date : 2020-04-01 Epub Date: 2020-03-17 DOI:10.23736/S0026-4784.20.04509-8
Tehila Feinberg, Michelle Rougerie, Yehuda S Dahan, Michael H Dahan
{"title":"非心血管并存疾病妇女使用激素避孕的综述全面审查。","authors":"Tehila Feinberg, Michelle Rougerie, Yehuda S Dahan, Michael H Dahan","doi":"10.23736/S0026-4784.20.04509-8","DOIUrl":null,"url":null,"abstract":"INTRODUCTION Previously, the American College of Obstetrics and Gynecology (ACOG) had published an excellent practice bulletin addressing the use of hormone contraception in women with pre-existing medical conditions. This practice bulletin became out of date. The Centers for Disease Control and prevention (CDC) of the United States subsequently developed a point form guideline for the use of oral contraceptives in women with co-existing medical conditions. EVIDENCE ACQUISITION Although this acts as a guide, it leaves the clinician without an understanding of why they are doing what they are doing. This article, is one of two related to women with co-existing medical conditions. EVIDENCE SYNTHESIS In this article we will provide an update of the scientific knowledge since the publication of the ACOG guideline (2006). It is to be used as a supplement for those who desire more information than is found in the CDC guidelines. CONCLUSIONS Although some recommendations have remained unchanged over the years, the development of lower dose contraceptive pills as well as the increased incidence of comorbid conditions, such as metabolic syndrome, in younger women seeking contraception has brought along new research and new evidence to guide clinicians in the prescription of these medications.","PeriodicalId":18745,"journal":{"name":"Minerva ginecologica","volume":"72 2","pages":"82-89"},"PeriodicalIF":1.0000,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A review of the use of hormonal contraception in women with non-cardiovascular coexisting medical conditions. A comprehensive review.\",\"authors\":\"Tehila Feinberg, Michelle Rougerie, Yehuda S Dahan, Michael H Dahan\",\"doi\":\"10.23736/S0026-4784.20.04509-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"INTRODUCTION Previously, the American College of Obstetrics and Gynecology (ACOG) had published an excellent practice bulletin addressing the use of hormone contraception in women with pre-existing medical conditions. This practice bulletin became out of date. The Centers for Disease Control and prevention (CDC) of the United States subsequently developed a point form guideline for the use of oral contraceptives in women with co-existing medical conditions. EVIDENCE ACQUISITION Although this acts as a guide, it leaves the clinician without an understanding of why they are doing what they are doing. This article, is one of two related to women with co-existing medical conditions. EVIDENCE SYNTHESIS In this article we will provide an update of the scientific knowledge since the publication of the ACOG guideline (2006). It is to be used as a supplement for those who desire more information than is found in the CDC guidelines. CONCLUSIONS Although some recommendations have remained unchanged over the years, the development of lower dose contraceptive pills as well as the increased incidence of comorbid conditions, such as metabolic syndrome, in younger women seeking contraception has brought along new research and new evidence to guide clinicians in the prescription of these medications.\",\"PeriodicalId\":18745,\"journal\":{\"name\":\"Minerva ginecologica\",\"volume\":\"72 2\",\"pages\":\"82-89\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2020-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Minerva ginecologica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23736/S0026-4784.20.04509-8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/3/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva ginecologica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S0026-4784.20.04509-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/3/17 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

导读:此前,美国妇产科学院(ACOG)发表了一份关于在已有疾病的妇女中使用激素避孕的优秀实践公告。这个实践公告已经过时了。美国疾病控制和预防中心(CDC)随后制定了一项针对患有并存疾病的妇女使用口服避孕药的要点指南。证据获取:尽管这是一种指导,但它使临床医生无法理解他们为什么要这样做。这篇文章是两篇与女性并存疾病相关的文章之一。证据综合:在本文中,我们将提供自ACOG指南(2006)发布以来的科学知识更新。对于那些希望获得比疾病预防控制中心指南更多信息的人来说,这是一种补充。结论:尽管一些建议多年来一直保持不变,但低剂量避孕药的发展以及寻求避孕的年轻女性的合并症(如代谢综合征)发生率的增加带来了新的研究和新的证据,以指导临床医生处方这些药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A review of the use of hormonal contraception in women with non-cardiovascular coexisting medical conditions. A comprehensive review.
INTRODUCTION Previously, the American College of Obstetrics and Gynecology (ACOG) had published an excellent practice bulletin addressing the use of hormone contraception in women with pre-existing medical conditions. This practice bulletin became out of date. The Centers for Disease Control and prevention (CDC) of the United States subsequently developed a point form guideline for the use of oral contraceptives in women with co-existing medical conditions. EVIDENCE ACQUISITION Although this acts as a guide, it leaves the clinician without an understanding of why they are doing what they are doing. This article, is one of two related to women with co-existing medical conditions. EVIDENCE SYNTHESIS In this article we will provide an update of the scientific knowledge since the publication of the ACOG guideline (2006). It is to be used as a supplement for those who desire more information than is found in the CDC guidelines. CONCLUSIONS Although some recommendations have remained unchanged over the years, the development of lower dose contraceptive pills as well as the increased incidence of comorbid conditions, such as metabolic syndrome, in younger women seeking contraception has brought along new research and new evidence to guide clinicians in the prescription of these medications.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Minerva ginecologica
Minerva ginecologica OBSTETRICS & GYNECOLOGY-
CiteScore
3.00
自引率
0.00%
发文量
0
期刊介绍: The journal Minerva Ginecologica publishes scientific papers on obstetrics and gynecology. Manuscripts may be submitted in the form of editorials, original articles, review articles, case reports, therapeutical notes, special articles and letters to the Editor. Manuscripts are expected to comply with the instructions to authors which conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Editors by the International Committee of Medical Journal Editors (www.icmje.org). Articles not conforming to international standards will not be considered for acceptance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信